Bioactivity-guided isolation of anti-inflammatory compounds from the herbs constituting a traditional Chinese medicine formulation used for the treatment of rheumatoid arthritis

Résumé fourni par la source

BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that poses a significant socio-economic burden. Traditional Chinese medicine (TCM) herbal formulations, with their long history of clinical use, represent a promising source for novel anti-rheumatic drugs. However, the complexity of RA pathogenesis and the chemical diversity of TCM formulations present challenges in understanding compound-target interactions. PURPOSE: This study aimed to identify the anti-inflammatory constituents from the individual plant species included in the clinically used TCM formulation ("Formulation A"), and to characterize their effects on key inflammatory pathways. Formulation A is currently undergoing a double-blind, randomized clinical trial. A key innovation of this work is the integration of a phenotypic screening strategy, bridging the gap between typical single-species natural product studies and formulation-level decoction studies. METHODS: ) in a fibroblast cell line were also evaluated. RESULTS: Plant species within Formulation A displayed a spectrum of biological activities, from minor to broad and more targeted effects. The strongest anti-inflammatory activities were observed in nonpolar extracts and fractions, reflecting the utility of organic solvent extraction for accessing pharmacologically potent constituents that may be underrepresented in traditional water-based decoctions. Two new compounds from Atractylodes lancea were identified, alongside 37 known compounds from other species exhibiting both new and previously known anti-inflammatory activities. These findings also highlight specific molecular effects of the formulation's components on inflammatory signaling pathways and mediators. CONCLUSION: This study provides mechanistic insights into the anti-inflammatory effects of plant constituents present in Formulation A, based on the systematic analysis of each individual plant species. Moreover, it establishes a robust phenotypic screening platform for the systematic discovery of new anti-rheumatic agents from natural sources.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.